ES554831A0 - Derivados de tetrazol - Google Patents

Derivados de tetrazol

Info

Publication number
ES554831A0
ES554831A0 ES554831A ES554831A ES554831A0 ES 554831 A0 ES554831 A0 ES 554831A0 ES 554831 A ES554831 A ES 554831A ES 554831 A ES554831 A ES 554831A ES 554831 A0 ES554831 A0 ES 554831A0
Authority
ES
Spain
Prior art keywords
tetrazole derivatives
tetrazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554831A
Other languages
English (en)
Other versions
ES8707951A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES554831A0 publication Critical patent/ES554831A0/es
Publication of ES8707951A1 publication Critical patent/ES8707951A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES554831A 1985-05-10 1986-05-09 Derivados de tetrazol Expired ES8707951A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858511895A GB8511895D0 (en) 1985-05-10 1985-05-10 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
ES554831A0 true ES554831A0 (es) 1987-09-01
ES8707951A1 ES8707951A1 (es) 1987-09-01

Family

ID=10578949

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554831A Expired ES8707951A1 (es) 1985-05-10 1986-05-09 Derivados de tetrazol

Country Status (7)

Country Link
US (1) US4831046A (es)
EP (1) EP0201349A3 (es)
JP (1) JPS6216478A (es)
ES (1) ES8707951A1 (es)
GB (1) GB8511895D0 (es)
GR (1) GR861208B (es)
PT (1) PT82551B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248780A (en) * 1988-02-16 1993-09-28 Imperial Chemical Industries, Plc Pyridyl substituted alkenoic acid derivatives
GB8901201D0 (en) * 1988-02-16 1989-03-15 Ici Plc Pyridine derivatives
US4839384A (en) * 1988-10-07 1989-06-13 E. R. Squibb & Sons, Inc. Method of inhibiting onset of or treating migraine headache using a thromboxane A2 receptor antagonist
IE81170B1 (en) * 1988-10-21 2000-05-31 Zeneca Ltd Pyridine derivatives
US4937355A (en) * 1989-01-17 1990-06-26 E. R. Squibb & Sons, Inc. Process for preparing (trans)-4-substituted-dl-proline derivatives
GB9021571D0 (en) * 1990-10-04 1990-11-21 Ici Plc Heterocyclic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3600437A (en) * 1969-05-28 1971-08-17 Lilly Co Eli Substituted phenylalkanoic acids and derivatives thereof
BE788209A (fr) * 1971-09-01 1973-02-28 Pfizer Derives tetrazoyliques des prostaglandines naturelles
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids

Also Published As

Publication number Publication date
US4831046A (en) 1989-05-16
PT82551A (en) 1986-06-01
GR861208B (en) 1986-08-29
EP0201349A3 (en) 1987-10-21
EP0201349A2 (en) 1986-11-12
JPS6216478A (ja) 1987-01-24
GB8511895D0 (en) 1985-06-19
ES8707951A1 (es) 1987-09-01
PT82551B (pt) 1988-08-17

Similar Documents

Publication Publication Date Title
DE3683188D1 (de) Substituierte tetrazolinone.
DK106786D0 (da) Heterocycliske forbindelser
FI895718A7 (fi) -amino-boronihappo-johdannaiset
ATA46188A (de) Antihypercholesterinaemische tetrazol-verbindungen
BR8600280A (pt) Porta-ferramentas
DK496086A (da) Heterocykliske forbindelser
DK219986A (da) Nitrogenholdige heterocycliske forbindelser
BR8602901A (pt) Acumulador de succao
BR8606663A (pt) Derivados de triazolil-quinolina
DK346786A (da) Penemderivater
DK109186D0 (da) Dihydropyridazinonderivater
ES554831A0 (es) Derivados de tetrazol
DE3650527D1 (de) Imidazolderivate
DK491786D0 (da) Dichloranilinderivater
DK556386D0 (da) Quinilinderivater
BR8901488A (pt) Acionamento de embolo
DK434586D0 (da) Amidinderivater ii
DK446486A (da) Phosphonamidderivater
NO178432C (no) Tetrazolmellomprodukt
DK303886A (da) Secocanthinderivater
DE3662889D1 (de) Tetrahydrofurancarboxylic-acid derivatives
KR880700821A (ko) 데--데옥시테이코플라닌 유도체
ES550434A0 (es) Procedimiento de obtencion de un derivado de tetrazol
DK397686D0 (da) Heterocycliske forbindelser
DK109586A (da) Heterocycliske forbindelser

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506